FOXO4 DRI 10mg

H1: FOXO4 DRI 10mg UK: Premium Senolytic Peptide for Cellular Senescence Research

FOXO4 DRI 10mg, also referred to as FOXO4-DRI, is a highly specialised synthetic senolytic peptide developed for advanced laboratory research into cellular senescence, tissue rejuvenation, and age-related biological processes. This cell-permeable D-retro-inverso peptide selectively targets senescent cells — often called “zombie cells” — by disrupting the FOXO4-p53 interaction, thereby promoting their programmed cell death (apoptosis) while largely sparing healthy, proliferating cells.

At Cocer Peptides UK, we supply high-purity FOXO4 DRI 10mg specifically for scientific and laboratory use across the United Kingdom. Every batch undergoes rigorous third-party HPLC testing to ensure >99% purity, accompanied by detailed Certificates of Analysis (COA). All our research compounds, including FOXO4 DRI 10mg, are sold strictly for in vitro and in vivo laboratory research purposes only and are not for human or veterinary consumption.

Researchers investigating senolytic strategies, healthy aging models, and interventions against age-related decline value the precision and quality of compounds available from Cocer Peptides. UK-based laboratories benefit from our fast, discreet nationwide delivery and dedicated researcher support.

[Shop FOXO4 DRI 10mg Now] and advance your senescence research with verified, high-quality material.

What Is FOXO4 DRI 10mg?

FOXO4-DRI is a modified peptide derived from the forkhead box O4 (FOXO4) transcription factor. The D-retro-inverso (DRI) modification enhances its stability and cell permeability, making it an effective tool for targeting the FOXO4-p53 axis in senescent cells.

Cellular senescence is a state in which cells permanently stop dividing in response to stress, DNA damage, or telomere shortening. While initially protective against cancer, the accumulation of senescent cells contributes to chronic inflammation (via the senescence-associated secretory phenotype, or SASP), tissue dysfunction, and many age-related conditions.

For foundational understanding, refer to the Wikipedia entry on cellular senescence.

Key Features of FOXO4 DRI 10mg at Cocer Peptides:

• 10mg lyophilized vial format ideal for precise dosing in research protocols.

• 99% purity verified by independent HPLC analysis.

• Batch-specific COA documentation for full traceability and reproducibility.
• Suitable for cell culture, animal models, and biochemical assays.

How FOXO4 DRI Works: Mechanisms of Action

Disrupting the FOXO4-p53 Interaction In senescent cells, FOXO4 sequesters p53 in nuclear bodies, preventing p53 from triggering apoptosis. FOXO4-DRI acts as a competitive antagonist with high affinity for p53, displacing FOXO4 and allowing p53 to initiate the apoptotic cascade specifically in damaged cells.

This leads to nuclear exclusion of phosphorylated p53, mitochondrial involvement, activation of BAX, and caspase-3-mediated apoptosis. Recent studies further detail its action via the p53/BCL-2/Caspase-3 signalling pathway in endothelial cells.

Read the landmark 2017 study: Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis (PMC).

Selectivity and Safety in Research Models Importantly, FOXO4-DRI shows minimal impact on non-senescent, healthy cells, providing a valuable research tool for studying selective senescent cell clearance without broad cytotoxicity.

Research Benefits and Applications of FOXO4 DRI

Anti-Aging and Longevity Research Clearance of senescent cells using FOXO4-DRI has demonstrated improvements in tissue function in naturally aged and accelerated-aging mouse models. Benefits observed include restored renal and liver function, better physical performance, and overall healthier aging phenotypes.

Testosterone Secretion and Reproductive Aging In aged mice, FOXO4-DRI targeted senescent Leydig cells, improving the testicular microenvironment and alleviating age-related decline in testosterone production.

Vascular and Endothelial Health Recent research shows FOXO4-DRI regulates endothelial cell senescence, improves aortic function, and delays vascular aging through p53 pathway modulation.

Cartilage and Joint Research FOXO4-DRI selectively removes senescent cells from in vitro expanded human chondrocytes, potentially enhancing cartilage regeneration potential.

Other Promising Areas

• Keloid fibroblast models and fibrosis.
• Lupus and autoimmune-related senescence.
• Chemotherapy-induced premature aging and tissue recovery.

These findings position FOXO4 DRI 10mg as a key compound in the growing field of senolytic research. Explore broader context in reviews on PubMed Central and Nature.

FOXO4 DRI 10mg vs Other Senolytics

Compared to small-molecule senolytics (such as dasatinib + quercetin), FOXO4-DRI offers a peptide-based, highly targeted mechanism focused on the FOXO4-p53 axis. Researchers often study it alone or in combination with other compounds like mitochondria peptides (e.g., MOTS-c) or additional senolytics to explore synergistic effects in longevity models.

Explore our full anti-aging peptides range or related senolytic research peptides.

Usage in Laboratory Research

FOXO4 DRI 10mg is commonly applied in:

• Cell culture experiments with senescent fibroblasts, endothelial cells, or chondrocytes.
• In vivo mouse models of natural aging, chemotherapy damage, or progeria.
• Biochemical assays examining protein interactions and apoptosis pathways.

Storage Recommendations: Keep lyophilized vials in a cool, dry place. For long-term stability, store at -20°C. Reconstitute according to standard laboratory protocols using sterile solvents.

UK Regulatory Note: Always ensure compliance with all applicable guidelines for research chemicals.

Disclaimer: Products from Cocer Peptides are for laboratory research use only.

Why Choose Cocer Peptides for FOXO4 DRI 10mg in the UK?

• Uncompromising Quality: >99% purity with full third-party verification.
• Transparency: Every batch includes accessible COA documents.
• Reliable Delivery: Fast, discreet UK shipping with tracking.
• Researcher Support: Expert guidance for bulk orders and protocol questions.
• Commitment to Science: Supporting reproducible, high-impact research.

[View Certificates of Analysis for FOXO4 DRI] and discover our commitment to research quality at Cocer Peptides.

[Image: foxo4-dri-10mg-vial-uk.jpg] Alt Text: High purity FOXO4 DRI 10mg research vial – Cocer Peptides UK Caption: Laboratory-grade FOXO4-DRI 10mg senolytic peptide for advanced cellular senescence and longevity research, >99% HPLC verified.

Frequently Asked Questions (FAQ)

What is FOXO4 DRI 10mg used for in research? It serves as a selective senolytic tool to study the clearance of senescent cells and its effects on tissue function, aging, and related pathologies.

How does FOXO4-DRI work at the molecular level? It competitively inhibits the FOXO4-p53 binding, enabling p53-driven apoptosis specifically in senescent cells. Foundational PMC study.

Can FOXO4 DRI 10mg be combined with other research peptides? Yes, researchers frequently pair it with compounds like mitochondria peptides for multi-pathway longevity studies.

Is FOXO4 DRI legal for research in the UK? Yes, when used for legitimate scientific laboratory purposes in accordance with regulations.

What purity level does Cocer Peptides provide?

99% purity, confirmed by independent HPLC testing with COA for each batch.

How should FOXO4 DRI 10mg be stored? Lyophilized form in a cool, dry environment; refrigeration or freezing recommended for extended periods.

Do you offer bulk purchasing options? Yes — contact us for bulk research inquiries.

Conclusion

FOXO4 DRI 10mg stands out as a powerful and selective research tool in the rapidly evolving field of senolytic peptides. By enabling targeted elimination of senescent cells, it supports investigations into restoring tissue homeostasis, mitigating age-related decline, and exploring new frontiers in longevity science.

Backed by influential studies published in Cell, Aging, Frontiers in Bioengineering and Biotechnology, Nature Communications Biology, and indexed on PubMed Central, FOXO4-DRI continues to generate valuable insights for researchers worldwide.

Cocer Peptides UK remains dedicated to equipping UK scientists with premium, rigorously tested compounds to drive meaningful discoveries in cellular biology and healthy aging research.

Call-to-Action [Shop FOXO4 DRI 10mg Now] for fast UK delivery and reliable research supply. [View COA/Lab Results] for complete transparency. Browse related peptides or our anti-aging peptides category.

Have questions about protocols or bulk needs? Contact Us today for personalised researcher support.